alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
AEGIS SEF | 2829 Technology Forest Boulevard, Suite 260 | The Woodlands, Texas 77381

December 22, 2022

Submitted via Portal

Mr. Christopher J. Kirkpatrick

Office of the Secretariat

U.S. Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

Re: Confidential Treatment Request –AEGIS SEF Exhibit N-1 Participant

Agreement

Dear Sir:

AEGIS SEF, LLC (“AEGIS SEF”) hereby requests that the U.S. Commodity Futures Trading

Commission (the “Commission”) accord confidential treatment to Exhibit N-1 Participant 

Agreement (“Exhibit”), which was submitted to the Commission as 40.6(d) Weekly Notification 

of Amended Terms and Conditions on this date. This request pertains to all material in the 

Exhibit. The Exhibit bears the designation “Confidential Treatment Requested by AEGIS SEF, 

LLC.”

This request for confidential treatment is made pursuant to Commission

Regulations 40.8, as Exhibit contains information that would reveal the

trade secrets or confidential commercial or financial information of AEGIS SEF and its

affiliates. 

Please contact the undersigned at 832-413-5973 or afurman@aegis-hedging.com with any 

questions regarding this matter.

Andrew Furman

Chief Compliance Officer

AEGIS SEF, LLC

2829 Technology Forest Blvd

Suite 260

The Woodlands, TX 77381
<PAGE>

                                                                    Exhibit 10.1

                            FORM OF LOCK-UP AGREEMENT

[DATE]

[List of Purchasers]

     Re:  Securities Purchase Agreement dated __, 2005 (the "Agreement") by and
          among, Euroseas Ltd., (the "Company") and the purchasers signatory
          thereto (each, a "Purchaser" and collectively referred to as the
          "Purchasers")

Ladies and Gentlemen:

     Defined terms not otherwise defined herein (the "Letter Agreement") shall
have the meanings set forth in the Agreement. Pursuant to Section 2.2(a) of the
Agreement and in satisfaction of a condition of the Purchasers' obligations
under the Agreement, the undersigned irrevocably agrees with the Purchasers
that, from the date hereof until the date that is the six month anniversary of
the Effective Date (such period, the "Restriction Period"), the undersigned
shall not sell, offer, pledge, contract to sell, grant any option for the sale
of, transfer or otherwise dispose of any of the Common Stock or Common Stock
Equivalents beneficially owned by, or issuable to, the undersigned (the
"Securities").

     The Company hereby agrees to notify its transfer agent of the provisions of
this Letter Agreement. The undersigned acknowledges and agrees that the Company
will be permitted to require that the Company's transfer agent place a stop
transfer instruction on all Securities beneficially owned by the undersigned,
reflecting this Letter Agreement, until the end of the Restriction Period. This
Letter Agreement shall be binding on successors and assigns of the undersigned
with respect to the Securities and any such successor or assign shall enter into
a similar agreement for the benefit of the Purchasers.

                                        Very truly yours,


                                        By:
                                            ------------------------------------
                                            Name:

ACKNOWLEDGED AND AGREED TO
THIS ___ DAY OF ____, 2005

EUROSEAS LTD.


By:
    ------------------------------------
Name:
Title:
Exhibit 10.6

                            THIRD AMENDMENT TO LEASE

     This Third  Amendment  to Lease  dated this 25th day of March,  1999 by and
between BCE ASSOCIATES, L.P. successor in interest to Linpro Edison Land Limited
and 1993 N-2 Properties No.3 Limited  Partnership  ("Landlord") and MEDJET, INC.
("Tenant").

     1)   By Lease  Agreement  dated May 13, 1994 and First  Amendment  to Lease
          dated  February 28,  1996,  Landlord and  Landlord's  predecessors  in
          interest  leased to Tenant  Suite 301 and 308  ("Suites  301 and 308")
          consisting of 4,982 gross rentable  square feet in Building #3 at 1090
          King Georges Post Road,  Edison,  New Jersey.  By Second  Amendment to
          Lease dated  December 13, 1996,  Landlord  also leased to Tenant Suite
          505 ("Suite 505")  consisting of 2,376 gross  rentable  square feet in
          Building #5 at 1090 King Georges Post Road,  Edison,  New Jersey.  The
          Lease and the First and Second  Amendment to Lease are hereby referred
          to as the "Lease".

     2)   By Termination  Agreement  dated January 12, 1999,  Landlord  released
          Tenant of its obligations on Suite 505 only as of January 31, 1999.

     3)   The term of the Lease for  Suites  301 and 308  expires  December  31,
          1999.

     4)   Landlord and Tenant  desire to extend the term of the Lease for Suites
          301 and 308 for an additional  five (5) year term (the "Renewal Term")
          to commence on January 1, 2000 and to terminate on December 31, 2004.

     5)   Tenant's Base Rent during the Renewal Term shall be as follows:

          A)   $69,598.44 per annum;  $5,799.88 per month for the period January
               1, 2000 through December 31, 2000.

          B)   $74,730.00 per annum;  $6,227.50 per month for the period January
               1, 2001 through December 31, 2001.

          C)   $80,210.20 per annum;  $6,684.18 per month for the period January
               1, 2002 through December 31, 2002.

          D)   $83,000.12 per annum;  $6,916.68 per month for the period January
               1, 2003 through December 31, 2003.

          E)   $83,448.50 per annum;  $6,954.04 per month for the period January
               1, 2004 through December 31, 2004.


<PAGE>

     6)   Tenant shall also remain responsible for Tenant Electric in the amount
          $5,781.24  per  annum;  $481.77  per month.  Tenant's  Base Year shall
          remain 1996.

     7)   Except as modified herein, all terms and conditions of the Lease shall
          remain in full force and effect.


BCE ASSOCIATES, L.P.
  BCE GP, INC.

By: /s/ Steven J. Denholtz
    ----------------------------------
        Steven J. Denholtz, President

MEDJET, INC.

By: /s/ Eugene I. Gordon
    ----------------------------------
        Eugene I. Gordon
# C_2017369EN.01003201.xml

| 30.10.2017 | EN | Official Journal of the European Union | C 369/32 |
| --- | --- | --- | --- |

30.10.2017

EN

Official Journal of the European Union

C 369/32

---

Action brought on 23 August 2017 — UD v Commission

(Case T-574/17)

(2017/C 369/44)

Language of the case: French

Parties

Parties

Applicant: UD (represented by: S. Orlandi and T. Martin, lawyers)

Applicant:

Defendant: European Commission

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the decision of 2 November 2016 by which the Commission refused to grant prior authorisation for the reimbursement of medical costs relating to the applicant’s medical treatment; |
| --- | --- |

—

annul the decision of 2 November 2016 by which the Commission refused to grant prior authorisation for the reimbursement of medical costs relating to the applicant’s medical treatment;

| — | order the European Commission to pay the costs. |
| --- | --- |

—

order the European Commission to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on a single plea in law, alleging a manifest error of assessment vitiating the ground for refusal to reimburse based on the alleged lack of scientific validity of the treatment at issue.

---
<Page>

      CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Post-Effective
Amendment No. 13 to the Registration Statement on Form N-4 (No. 333-43799)
(the "Registration Statement") of our report dated March 31, 2005, relating
to the consolidated financial statements of Fortis Benefits Insurance Company
(as of September 6, 2005, known as Union Security Insurance Company), which
appears in such Registration Statement. We also consent to the reference to
us under the heading "Independent Registered Public Accounting Firm" in such
Registration Statement.

PRICEWATERHOUSECOOPERS LLP
Minneapolis, Minnesota
October 21, 2005
#### Millennium Partners, L.P., Appellant, v Select Insurance Company, Respondent, et al., Defendant.

Decided May 4, 2010

Appeal dismissed, without costs, by the Court of Appeals, sua sponte, upon the ground that no substantial constitutional question is directly involved.
Exhibit 3.1



Amendment to Amended and Restated Articles of Incorporation



The Amended and Restated Articles of Incorporation of the Corporation, as amended, be amended to add an Article Eighth as follows:



Eighth. Certificated and Uncertificated Shares.   Notwithstanding anything herein to the contrary, any or all classes and series of shares, or any part thereof, may be represented by uncertificated shares to the extent determined by the Board of Directors, except that shares represented by a certificate that is issued and outstanding shall continue to be represented thereby until the certificate is surrendered to the Corporation. Within a reasonable time after the issuance or transfer of uncertificated shares, the Corporation shall send to the registered owner thereof a written notice containing the information required to be set forth or stated on certificates under Section 1528(c) and (d) of the Pennsylvania Business Corporation Law of 1988, as amended (or any successor statute). Except as otherwise expressly provided by law, the rights and obligations of the holders of shares
represented by certificates and the rights and obligations of the holders of uncertificated shares of the same class and series shall be identical.

---
| Subsidiary                              | Jurisdiction of Organization |
|-----------------------------------------|------------------------------|
| Micrel International, Inc.              | Delaware                     |
| Micrel Semiconductor (UK) Limited       | United Kingdom               |
| Micrel Semiconductor Japan K.K.         | Japan                        |
| Micrel Semiconductor GMBH               | Germany                      |
| Micrel Semiconductor France             | France                       |
| Micrel Semiconductor Taiwan, Limited    | Taiwan                       |
| Micrel Semiconductor Hong Kong, Limited | Hong Kong                    |
| Micrel Semiconductor New Zealand        | New Zealand                  |
| Micrel Semiconductor (Spain) SRL        | Spain                        |
| Micrel SDN BHD                          | Malaysia                     |
| Micrel PTE Ltd                          | Singapore                    |
| Micrel Norway AS                        | Norway                       |
| Micrel (Shanghai) Incorporated          | China                        |
Ex. 31





CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002



The undersigned, Louis L. Knickerbocker and William C. Hitchcock, certify that:



1.

We have reviewed this report on Form 10-KSB of R.G. Global Lifestyles, Inc.



2.

Based upon our knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.



3.

Based on our knowledge, the financial statements, consolidated financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.



4.

The registrants other certifying officers and we are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:



a)

designed such disclosure controls and procedures to ensure that material information relating to the registrant, including any subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this report (the Evaluation Date); and

c)

presented in this report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;



5.

The registrants other certifying officers and we have disclosed, based upon our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors or persons performing the equivalent function):



a)

all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data, and have identified for the registrants auditors any material weaknesses in internal controls; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and



6.

The registrants other certifying officers and we have indicated in this report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.



Dated:  October 19, 2004





/s/ Louis L. Knickerbocker

Louis L. Knickerbocker, Chairman and Chief Executive Officer



/s/ William C. Hitchcock

William C. Hitchcock, Chief Financial Officer
**EXHIBIT 2.11****James Hardie — Form of 364-day Facility Agreement**Schedule 3 — Extension Request (clause 5.2)   **To:** **(Financier) #1#**   **Date:** **1 May 2005****ExtensionRequest — James Hardie — 364-day Facility Agreement dated#2# June 2005 between JamesHardies International Finance BV (“Borrower” and “Obligors’ Agent) and #1# (“Financier”) (“FacilityAgreement”)**In accordance with clause 5.2 (“Extension of Maturity Date”) of the Facility Agreement, theObligors’ Agent requests as follows;We requestthat the Maturity Date under the Facility Agreement in respect of US$#3# be extended toa date 182 days after the current Maturity Date under the Facility Agreement.TheMaturity Date, if extended in accordance with this request, will be #4# June 2007.If this extension request is accepted, the Facility Limit applicable from the current Maturity Datewill be US$#2#.     /s/ Nita Moritz-Jotwani /s/ Karen Hughes       **Nita Moritz-Jotwani**being an Authorised Officer of **Karen Hughes**being an
<PAGE>
                              EXHIBIT 23.1(d)


                CONSENT OF INDEPENDENT PETROLEUM CONSULTANTS


          We consent to the use, in the Securities and Exchange Commission
Form 10-KSB (Amendment No. 1) (the "10-KSBA") for the fiscal year ended
December 31, 1997 of Energy Search, Incorporated (the "Company") of our
report dated March 4, 1998 on the oil and gas reserves of the Company as of
January 1, 1998.  We also consent to the reference in the 10-KSBA to Wright
& Company, Inc. as experts in oil and gas analysis.



                                       Wright & Company, Inc.

                                       By: /S/ D. RANDALL WRIGHT
                                           D. Randall Wright, President


September 16, 1998
Brentwood, Tennessee
Exhibit
No. 31.2
 Form
10-Q
 First
Quantum Ventures, Inc.
 File
No. 000-52759
 CERTIFICATION
OF CHIEF FINANCIAL OFFICER PURSUANT TO
 SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002
 
 I,Andrew Godfrey, certify
that:
 
 1. I have
reviewed this quarterly report on Form 10-Q of First Quantum Ventures,
Inc.;
 
 2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact  necessary to make the
statements made, in light of the  circumstances  under which
such statements were made, not misleading with respect to the period covered by
this report;
 
 3.  Based  on
my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows
of the registrant as of, and for, the periods presented in this
report;
 
 4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and we have:
 
 a.  designed  such  disclosure  controls  and  procedures,  or
caused  such disclosure  controls and  procedures
to be designed  under our  supervision,  to ensure
that  material  information  relating to
the  registrant,  including  its consolidated
subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this report is being
prepared;
 b.
evaluated the effectiveness of the registrant's  disclosure controls
and procedures and presented in this report our conclusions  about the
effectiveness of the disclosure  controls and
procedures,  as of the end of the period covered by this quarterly
report based on such evaluation; and
 c.
disclosed in this report any change in the registrant's internal control
over  financial  reporting  that
occurred  during the  registrant's  most recent
fiscal  quarter  that  has  materially  affected,  or
is  reasonably  likely  to materially affect, the
registrant's  internal control over financial  reporting;
and
 
 5. I
have  disclosed,  based on our most
recent  evaluation of internal  control over financial
reporting,  to the registrant's  auditors and the audit
committee of the  registrant's  board of directors (or
persons  performing  the equivalent functions):
 
 a.
all significant  deficiencies  and
material  weaknesses in the design or operation of
internal  control
over  financial  reporting,  which are reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and
 b.
any fraud,  whether or not material,  that
involves  management or other employees who have a significant role in
the registrant's  internal control over financial
reporting.
 
 Date:
November 12, 2009
 
 /s/
Andrew
Godfrey
 Andrew
Godfrey
 Chief
Accounting Officer
Exhibit 32.1

CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Total Nutraceutical Solutions, Inc. (the Company) for the quarter ended September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), Marvin Hausman, M.D., Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|                          |     |                         
|------------------------- | --- | ------------------------
|Dated:  November 23, 2009 | By: | /s/ Marvin Hausman, M.D.
|                          |     | Marvin Hausman, M.D.    
|                          |     | Chief Executive Officer 

This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit D-2

41%. 59%
100%

TOO% TOO%.

98%

100%]

100%]
|                  |   |                                      |
|-----------------------|--------|-------------------------------------------|
|                  |   |                                      |   |
| February      9, 2010 |   | /s/ Russell      W. Mitchell         |   |
|                  |   | RUSSELL W.      MITCHELL                  |   |
|                  |   | Chairman      and Chief Executive Officer |   |
|                  |   |                                      |   |

|                  |   |                                       |
|-----------------------|--------|--------------------------------------------|
|                  |   |                                       |   |
| February      9, 2010 |   | /s/James      W. Higgins                   |   |
|                  |   | RUSSELLJAMES W.      HIGGINS               |   |
|                  |   | Chief      Financial and Operating Officer |   |
|                  |   |                                       |   |
# C_2020304EN.01001301.xml

| 14.9.2020 | EN | Official Journal of the European Union | C 304/13 |
| --- | --- | --- | --- |

14.9.2020

EN

Official Journal of the European Union

C 304/13

---

Order of the President of the Second Chamber of the Court of 2 March 2020 (request for a preliminary ruling from the Tribunal d'instance Epinal — France) — Cofidis SA v YU, ZT

(Case C-616/18) (1)

(2020/C 304/15)

Language of the case: French

The President of the Second Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 436, 3.12.2018.

---
**CERTIFICATION
      PURSUANT TO 18 USC, SECTION 1350,**


**AS
      ADOPTED PURSUANT TO SECTION 906**


**OF
      THE SARBANES-OXLEY ACT OF 2002**








In
      connection with the Annual Report of China Agro Sciences Corp. (the “Company”)
      on Form 10-K for the year ended September 30, 2006, as filed with the Securities
      and Exchange Commission on or about the date hereof (the “Report”), I, Zhengquan
      Wang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
      Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002,
      that:





(1)  The
      Report fully complies with the requirements of Sections 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)  Information
      contained in the Report fairly presents, in all material respects, the financial
      condition and results of operations of the Company.





Date: January
                16, 2007
              By:
              /s/ Zhengquan
                WangZhengquan
                  WangIts:
                  President


A
      signed
      original of this written statement required by Section 906 has been provided
      to
      China Agro Sciences Corp. and will be retained by China Agro Sciences Corp.
      and
      furnished to the Securities and Exchange Commission or its staff upon
      request.